Patients with IBD have significantly increased IgA-producing PCs in their intestinal mucosa, leading to the local production of large amounts of IgA, elevated serum IgA levels, and a systemic IgA immune response that may affect other organs, such as the kidneys [83, 84]. This evidence concerns the gene CD79A and inflammatory bowel disease.